Stroke Volume Variation (SVV) and Pulse Pressure Variation (PPV) are dynamic measurements used to assess a patient's fluid responsiveness, rather than providing direct measures of preload or the absolute volume of blood in the heart. These variables have demonstrated higher sensitivity and specificity for determining fluid responsiveness compared to traditional measures like heart rate, mean arterial pressure, central venous pressure, pulmonary artery diastolic pressure, and pulmonary artery occlusion pressure. Generally, an SVV higher than 13% suggests a patient is likely to respond positively to fluid administration, with the aim being to maintain SVV below 13%.
The underlying mechanism of SVV involves the natural fluctuations in arterial pulse pressure related to changes in intra-thoracic pressure during the breathing cycle. In spontaneously breathing patients, arterial pulse pressure decreases with inspiration and increases with expiration due to the effects of negative pressure ventilation on intra-thoracic pressure. Under controlled mechanical ventilation, SVV typically ranges from 10-15%, reflecting the changes in arterial pressure due to positive pressure ventilation.
SVV is particularly relevant only in fully mechanically ventilated patients with set tidal volumes above 8 mL/kg and fixed respiratory rates. Management based on SVV readings includes initiating vasopressors or inotropes if SVV is below 13% but mean arterial pressure remains under 65, or administering a 250 mL fluid bolus over 5 minutes if SVV exceeds 13%. The response to this fluid challenge determines further interventions, aiming to adjust SVV to below 13%.
However, several factors limit the reliability of SVV measurements. These include the presence of arrhythmias, alterations in vascular tone (which may artificially increase SVV readings), the application of high positive end-expiratory pressure (PEEP), and challenges in spontaneously breathing patients due to the smaller tidal volumes and associated changes in ventricular loading conditions. These limitations underscore the necessity of considering the individual clinical context when interpreting SVV and PPV data to guide fluid management.
| Parameter | Value or action |
|---|---|
| Target | Maintain SVV below 13% |
| SVV above 13% | Patient is likely fluid responsive → give a 250 mL bolus over 5 minutes |
| SVV below 13% with MAP under 65 | Initiate vasopressors or inotropes |
| Typical range on controlled ventilation | 10–15% |
| Validity requirements | Fully mechanically ventilated, set tidal volume above 8 mL/kg, fixed respiratory rate |
| Factors limiting reliability | Arrhythmias, altered vascular tone (may falsely raise SVV), high PEEP, spontaneous breathing |
